380 related articles for article (PubMed ID: 16394852)
21. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.
Bonnet F; Morlat P; Chêne G; Mercié P; Neau D; Chossat I; Decoin M; Djossou F; Beylot J; Dabis F;
HIV Med; 2002 Jul; 3(3):195-9. PubMed ID: 12139658
[TBL] [Abstract][Full Text] [Related]
22. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
23. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.
Pacheco AG; Tuboi SH; May SB; Moreira LF; Ramadas L; Nunes EP; Merçon M; Faulhaber JC; Harrison LH; Schechter M
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):624-30. PubMed ID: 19430304
[TBL] [Abstract][Full Text] [Related]
24. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
25. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
26. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
27. Trends and characteristics of all-cause mortality among HIV-infected inpatients during the HAART era (2006-2015) in Shanghai, China.
Ji Y; Wang Z; Shen J; Chen J; Yang J; Qi T; Song W; Tang Y; Liu L; Shen Y; Zhang R; Lu H
Biosci Trends; 2017 Mar; 11(1):62-68. PubMed ID: 28132999
[TBL] [Abstract][Full Text] [Related]
28. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
Am J Epidemiol; 2013 Jan; 177(2):116-25. PubMed ID: 23287403
[TBL] [Abstract][Full Text] [Related]
29. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.
Smith DK; Gardner LI; Phelps R; Hamburger ME; Carpenter C; Klein RS; Rompalo A; Schuman P; Holmberg SD;
J Urban Health; 2003 Dec; 80(4):676-88. PubMed ID: 14709715
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and causes of death in the Australian HIV Observational Database.
Petoumenos K; Law MG;
Sex Health; 2006 May; 3(2):103-12. PubMed ID: 16800396
[TBL] [Abstract][Full Text] [Related]
31. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
32. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
[TBL] [Abstract][Full Text] [Related]
33. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
34. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
35. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.
Cohen MH; French AL; Benning L; Kovacs A; Anastos K; Young M; Minkoff H; Hessol NA
Am J Med; 2002 Aug; 113(2):91-8. PubMed ID: 12133746
[TBL] [Abstract][Full Text] [Related]
36. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
37. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
38. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
[TBL] [Abstract][Full Text] [Related]
39. Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy.
Sabin CA; Yee TT; Devereux H; Griffioen A; Loveday C; Phillips AN; Lee CA
AIDS; 2000 May; 14(8):1001-7. PubMed ID: 10853982
[TBL] [Abstract][Full Text] [Related]
40. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan.
Hung CC; Hsiao CF; Chen MY; Hsieh SM; Chang SY; Sheng WH; Sun HY; Chang SC
Jpn J Infect Dis; 2006 Aug; 59(4):222-8. PubMed ID: 16936339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
